ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 59 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $507,000 | -27.4% | 219,420 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $698,000 | -22.4% | 219,420 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $900,000 | -9.3% | 219,420 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $992,000 | +35.7% | 219,420 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $731,000 | -50.2% | 219,420 | +37.6% | 0.00% | -50.0% |
| Q1 2017 | $1,468,000 | -17.3% | 159,420 | -30.8% | 0.00% | -20.0% |
| Q4 2016 | $1,776,000 | -32.5% | 230,400 | 0.0% | 0.01% | -28.6% |
| Q3 2016 | $2,633,000 | +176.6% | 230,400 | +197.8% | 0.01% | +250.0% |
| Q2 2016 | $952,000 | -49.0% | 77,370 | -58.0% | 0.00% | -60.0% |
| Q1 2016 | $1,865,000 | – | 184,430 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|